Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003140740 | SCV003820811 | uncertain significance | Emery-Dreifuss muscular dystrophy 5, autosomal dominant | 2019-06-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246074 | SCV003958536 | uncertain significance | not specified | 2023-04-06 | criteria provided, single submitter | clinical testing | The c.4936G>C (p.A1646P) alteration is located in exon 34 (coding exon 33) of the SYNE2 gene. This alteration results from a G to C substitution at nucleotide position 4936, causing the alanine (A) at amino acid position 1646 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |